小范围肝切除治疗Bismuth-Corlette Ⅲ、Ⅳ型肝门部胆管癌的临床效果
该回顾性研究分析108例Bismuth-Corlette Ⅲ、Ⅳ型肝门部胆管癌患者,比较小范围肝切除(≤3个肝段,70例)与大范围肝切除(>3个肝段,38例)的疗效。结果显示小范围组手术时间更短、术中出血量更少、术后并发症发生率更低,而两组1、3、5年累积总体生存率无显著差异。结论认为对经选择患者小范围肝切除可获得较好远期结局,陈氏胆肠吻合法简单安全有效。
要点
- 小范围肝切除(≤3个肝段)组手术时间(180±25)min,短于大范围组(210±35)min(P<0.05)。
- 小范围组术中出血量(310±80)ml,少于大范围组(500±110)ml(P<0.05)。
- 两组1、3、5年累积总体生存率无显著差异(P值分别为0.674、0.946、0.865)。
核心结论
- 对经选择Bismuth-Corlette Ⅲ、Ⅳ型肝门部胆管癌患者,小范围肝切除较大范围肝切除获得更好长期结局。
- 陈氏胆肠吻合法简单、有效、安全,在多处胆肠吻合时可广泛推广使用。
研究设计与样本
- 回顾性分析2007年5月至2017年5月临沂市肿瘤医院肝胆外科108例接受手术切除的Bismuth-Corlette Ⅲ、Ⅳ型肝门部胆管癌患者资料。
- 男性56例,女性52例,年龄(57.2±5.3)岁(范围48~76岁);Ⅲa型51例,Ⅲb型40例,Ⅳ型17例。
- 小范围肝切除(≤3个肝段)70例,大范围肝切除(>3个肝段)38例。
主要发现
- 小范围肝切除组手术时间(180±25)min,短于大范围组(210±35)min(t′=4.676,P<0.05)。
- 小范围组术中出血量(310±80)ml,少于大范围组(500±110)ml(t′=9.385,P<0.05)。
- 小范围组术后并发症发生率低于大范围组(χ²=5.230,P<0.05)。
- 小范围组和大范围组1、3、5年累积总体生存率分别为87.1%、58.4%、30.0%和84.2%、57.9%、31.6%,两组比较无显著差异(χ²=0.177,P=0.674;χ²=0.005,P=0.946;χ²=0.029,P=0.865)。
关键数值与推荐
- 小范围肝切除定义为≤3个肝段切除,包括4b段切除8例、4b段+5段切除28例、部分4段+部分7段+部分1段切除34例。
- 大范围肝切除定义为>3个肝段切除,包括2段+3段+4段+1段切除30例、5段+7段+8段+1段切除8例。
临床怎么用
- 对经选择的Bismuth-Corlette Ⅲ、Ⅳ型肝门部胆管癌患者,可考虑采用小范围肝切除以缩短手术时间、减少出血和并发症。
- 在多处胆肠吻合时可采用陈氏胆肠吻合法。
局限性
- 本研究为单中心回顾性分析,样本量108例,结论需前瞻性研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore the clinical effect and safety of minor liver resection for hilar cholangiocarcinoma (HC) of Bismuth-Corlette type Ⅲ and Ⅳ. Methods: From May 2007 to May 2017, the clinical data of 108 patients with Bismuth-Corlette type Ⅲ and Ⅳ HC underwent hepatectomy were collected and analyzed retrospectively.There were 56 males and 52 females, aged (57.2±5.3) years (ranged 48-76 years) .Among the 108 cases, there were 51 cases of type Ⅲa, 40 cases of type Ⅲb and 17 cases of type Ⅳ. Small-scale hepatectomy (≤3 hepatectomy) was performed in 70 cases, including 8 cases of 4b segment resection, 28 cases of 4b segment+5 segment resection, and 34 cases of partial 4 segment+partial 7 segment+partial 1 segment resection. Large-scale hepatectomy was performed in 38 cases (>3 segments) , of which 30 cases were treated with 2 segments+3 segments+4 segments+1 segment, and 8 cases were treated with 5 segments+7 segments+8 segments+1 segment. t' test was used to analyze the data which did not conform to the normal distribution, and χ(2) test was used to calculate the incidence of postoperative complications and the 1, 3, and 5-year cumulative overall survival rate. Results: (1) The operation time of minor liver resection group ((180±25)minutes) was shorter than that of major liver resection group ((210±35)minutes) (t'=4.676, P<0.05) , the amount of blooding operation time of minor liver resection group ((310±80)ml) was less than that of major liver resection group ((500±110)ml)in the operation (t'=9.385, P<0.05) , and the difference was statistically significant. (2) The incidence of complications was lower in minor liver resection group and major liver resection group, and the difference was statistically significant (χ(2)=5.230, P<0.05) . (3) The actual 1-, 3- and 5-year survival rates were 87.1%, 58.4%, 30.0% and 84.2%, 57.9%,31.6%, respectively. There were no significant differences in survival rates in two groups in 1-, 3- and 5-year survival rates (χ(2)=0.177, P=0.674; χ(2)=0.005, P=0.946; χ(2)=0.029, P=0.865) . Conclusions: Compared to patients with major liver resection, Minor liver resection for selected patients with HC of Bismuth-Corlette Ⅲ and Ⅳaccording to our criteria achieved better long-term outcomes. Chen's biliojejunostomy is a simple, effective and safe method, which can be widely used when there are multiple biliary intestinal anastomosese. 目的: 探讨小范围肝切除治疗Bismuth-Corlette Ⅲ、Ⅳ型肝门部胆管癌的临床效果及安全性。 方法: 回顾性分析2007年5月至2017年5月在临沂市肿瘤医院肝胆外科接受手术切除的108例Bismuth-Corlette Ⅲ、Ⅳ型肝门部胆管癌患者资料,其中男性56例,女性52例,年龄(57.2±5.3)岁(范围:48~76岁)。Ⅲa型51例,Ⅲb型40例,Ⅳ型17例。小范围肝切除(≤3个肝段切除)70例:肝脏4b段切除8例,4b段+5段切除28例,部分4段+部分7段切除+部分1段切除34例。大范围肝切除38例(>3个肝段):肝脏2段+3段+4段+1段切除30例,5段+7段+8段+1段切除8例。不符合正态分布的计量资料采用t′检验进行统计学分析,对术后并发症发生率及1、3、5年累积总体生存率的统计采用χ(2)检验。 结果: (1)小范围肝切除组与大范围肝切除组相比,手术时间短[(180±25)min比(210±35)min](t′=4.676,P<0.05),术中出血量少[(310±80)ml比(500±110)ml](t′=9.385,P<0.05)。(2)小范围组与大范围组相比术后并发症发生率低(χ(2)=5.230,P<0.05)。(3)小范围肝切除和大范围肝切除术后1、3、5年累积总体生存率分别为87.1%、58.4%、30.0%和84.2%、57.9%、31.6%,两组相比较无明显差异(χ(2)=0.177,P=0.674;χ(2)=0.005,P=0.946;χ(2)=0.029,P=0.865)。 结论: 小范围肝切除治疗Bismuth-Corlette Ⅲ、Ⅳ型肝门部胆管癌疗效确切,陈氏肝肠吻合法简单、安全、有效,可以广泛推广使用。.
引用
- Li ES, Sun YL, Liu XJ, et al. [Minor liver resection for hilar cholangiocarcinoma of Bismuth-Corlette type Ⅲ and Ⅳ]. Zhonghua Wai Ke Za Zhi. 2019. PMID: 31269615. doi:10.3760/cma.j.issn.0529-5815.2019.07.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。